- Investing Ideas
- /
- U.S. Solid Balance Sheet and Fundamentals
U.S. Solid Balance Sheet and Fundamentals
UPDATED Sep 23, 2022
High return on equity, past performance and sound balance sheet.
136 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HUBGHub Group | US$68.31 | -4.9% | -2.4% | US$2.4b | US$96.25 | PE7.4x | E-10.5% | n/a | Transportation | ||
| STLDSteel Dynamics | US$70.19 | -6.4% | 17.3% | US$12.8b | US$86.83 | PE2.9x | E-29.2% | 1.9% | Materials | ||
| GLNGGolar LNG | US$23.48 | -10.4% | 101.9% | US$2.5b | US$32.25 | PE4.3x | E-48.7% | 0% | Energy | ||
| TXTernium | US$27.88 | -1.3% | -35.4% | US$5.5b | US$48.46 | PE1.4x | E-24.4% | 12.9% | Materials | ||
| MOSMosaic | US$48.53 | -7.0% | 35.3% | US$16.8b | US$67.61 | PE5.1x | E-33.0% | 1.2% | Materials | ||
| TMSTTimkenSteel | US$14.44 | -4.4% | 10.0% | US$667.5m | US$25.55 | PE3.1x | E-33.9% | 0% | Materials | ||
| MRNAModerna | US$123.64 | -10.2% | -71.3% | US$48.4b | US$214.75 | PE3.4x | E-39.1% | n/a | Pharmaceuticals & Biotech | ||
| HZOMarineMax | US$30.00 | -1.4% | -40.1% | US$646.0m | US$50.29 | PE3.4x | E-3.7% | n/a | Retail | ||
| PSBPS Business Parks | US$187.44 | 0.2% | 21.1% | US$6.5b | n/a | PB4.8x | E-41.1% | 2.2% | Real Estate | ||
| PBFPBF Energy | US$29.88 | 5.5% | 143.9% | US$3.7b | US$40.25 | PE2.6x | E-48.8% | 0% | Energy | ||
| RFPResolute Forest Products | US$20.20 | -0.8% | 68.9% | US$1.6b | US$22.80 | PE3.7x | E-28.3% | n/a | Materials | ||
| IPIIntrepid Potash | US$38.31 | -7.3% | 24.3% | US$506.8m | US$45.00 | PE1.8x | S-11.2% | n/a | Materials | ||
| XUnited States Steel | US$18.59 | -7.7% | -14.9% | US$4.4b | US$24.74 | PE0.9x | E-65.0% | 1.1% | Materials | ||
| HTOOFusion Fuel Green | US$5.35 | -20.3% | -52.1% | US$71.1m | US$16.00 | PE3.1x | E-36.0% | n/a | Capital Goods | ||
| BNTXBioNTech | US$128.35 | -11.9% | -61.5% | US$31.2b | US$213.56 | PE2.7x | E-39.6% | n/a | Pharmaceuticals & Biotech | ||
| VIRVir Biotechnology | US$18.59 | -7.1% | -57.6% | US$2.5b | US$46.78 | PE2.3x | E-40.6% | n/a | Pharmaceuticals & Biotech |